Tygh Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tygh Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$8.96M	Buy	80,031 +328	+0.4%	+$39.6K	1.15%	41
2021 Q3	$10M	Buy	79,703 +1,235	+2%	+$159K	1.36%	31
2021 Q2	$10.6M	Sell	78,468 -982	-1%	-$129K	1.45%	25
2021 Q1	$10.8M	Buy	79,450 +2,481	+3%	+$371K	1.52%	27
2020 Q4	$10.8M	Sell	76,969 -2,910	-4%	-$373K	1.69%	15
2020 Q3	$8.9M	Buy	79,879 +1,626	+2%	+$182K	1.69%	19
2020 Q2	$8.76M	Sell	78,253 -19,123	-20%	-$1.88M	1.83%	16
2020 Q1	$7.54M	Buy	97,376 +1,054	+1%	+$93.3K	1.69%	25
2019 Q4	$9.16M	Buy	+96,322	New	+$8.33M	1.51%	28
2019 Q2	–	Sell	-102,421	Closed	-$9.27M	–	87
2019 Q1	$9.27M	Buy	102,421 +39,847	+64%	+$3.39M	1.63%	22
2018 Q4	$4.49M	Buy	62,574 +19,479	+45%	+$1.57M	0.94%	48
2018 Q3	$4.13M	Sell	43,095 -1,871	-4%	-$181K	0.68%	66
2018 Q2	$4.28M	Sell	44,966 -45,359	-50%	-$4.17M	0.72%	68
2018 Q1	$7.92M	Buy	90,325 +27,351	+43%	+$2.5M	1.51%	23
2017 Q4	$5.34M	Sell	62,974 -1,710	-3%	-$143K	1.01%	43
2017 Q3	$5.6M	Buy	64,684 +4,722	+8%	+$379K	1.12%	41
2017 Q2	$4.63M	Sell	59,962 -1,545	-3%	-$110K	1.05%	50
2017 Q1	$4.26M	Buy	61,507 +2,175	+4%	+$146K	1%	53
2016 Q4	$3.51M	Buy	+59,332	New	+$3.66M	0.88%	56
2016 Q1	–	Sell	-27,853	Closed	-$1.96M	–	98
2015 Q4	$1.96M	Buy	27,853 +620	+2%	+$42.3K	0.55%	70
2015 Q3	$1.7M	Sell	27,233 -55,693	-67%	-$4.39M	0.4%	80
2015 Q2	$6.97M	Sell	82,926 -57	-0.1%	-$4.43K	1.25%	32
2015 Q1	$6.24M	Sell	82,983 -2,091	-2%	-$146K	1.15%	33
2014 Q4	$5.29M	Buy	+85,074	New	+$4.85M	1.02%	41

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Tygh Capital Management's XBI Position: Q4 2021 in Review

Tygh Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.41% in Q4 2021, buying an estimated $39.6K and bringing the position to 80,031 shares worth $8.96M. The position accounts for 1.15% of the portfolio, ranked #41.

Tygh Capital Management first reported a position in XBI in Q4 2014 and has held it in 24 quarters since. The position peaked at $10.8M in Q4 2020. 700 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Tygh Capital Management held 80,031 shares of State Street SPDR S&P Biotech ETF worth $8.96M as of Q4 2021.
Tygh Capital Management bought 328 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $39.6K.
State Street SPDR S&P Biotech ETF made up 1.15% of Tygh Capital Management's portfolio in Q4 2021, its #41 holding.
Tygh Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and has held it in 24 quarters since.
Tygh Capital Management's State Street SPDR S&P Biotech ETF position peaked at $10.8M in Q4 2020.
700 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.